IOL Chemicals Declares Interim Dividend of ₹1; Sets Feb 17 as Record Date
IOL Chemicals declared an interim dividend of ₹1 per share for FY 2025-26. The record date is February 17, 2026. TDS rules apply, with a ₹10,000 threshold for no deduction for resident individuals. Declarations for intermediaries are due by February 17, 2026.
The declaration of an interim dividend and the associated TDS information are routine corporate actions and do not represent a significant strategic shift or financial event that would have a substantial impact on the company's stock or market position.
The announcement is a routine declaration of an interim dividend and details the associated tax implications, which are standard procedures. It does not contain significant positive or negative news for the company's performance.
IOL Chemicals and Pharmaceuticals Limited has announced the declaration of an interim dividend of ₹1 per equity share (50%) for the financial year 2025-26. The Board of Directors made this decision during a meeting held on February 11, 2026. The company has fixed February 17, 2026, as the record date to determine the eligibility of shareholders for this interim dividend.
The announcement also details the Tax Deduction at Source (TDS) provisions applicable to this dividend as per the Income Tax Act, 1961. Resident shareholders with an inoperative PAN will face a 20% TDS deduction. However, no TDS will be deducted if the dividend amount for an individual resident shareholder does not exceed ₹10,000. Shareholders holding shares through intermediaries or stockbrokers are required to provide necessary declarations by February 17, 2026, through the Alankit Assignments Limited portal.
All forms and declarations must be submitted by February 17, 2026, to ensure appropriate TDS is applied. The company has also advised shareholders to register their email addresses and ensure their bank account details are updated with their Demat accounts for timely dividend credit. TDS certificates will be emailed post-payment, and the TDS amount will be reflected in Form 26AS.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.